Co-Founder and Chief Scientific Officer
Novome Biotechnologies
Dr. DeLoache is Co-Founder and Chief Scientific Officer of Novome Biotechnologies, a biotechnology company based in South San Francisco that is engineering bacterial therapeutics for chronic diseases. Until 2019, he served as President and CEO of the company, helping to raise a combined $40M in financing. Prior to Novome, he worked as a Scientist at Zymergen, where he led the development of the company’s next-generation sequencing pipeline. Dr. DeLoache earned his Ph.D. in Bioengineering at the University of California, Berkeley, studying synthetic biology and metabolic engineering in the laboratory of John Dueber. He received his B.S. with Honors in Biology from Davidson College.